logo

Pacira Pharmaceuticals, Inc. (PCRX)



Trade PCRX now with
  Date
  Headline
8/6/2018 7:56:31 AM Wedbush Is Raising Pacira Pharmaceuticals, Inc. (PCRX) FY19 Rev. Estimate To 351.2 M From 350.2 M
8/6/2018 7:56:21 AM Wedbush Is Raising Pacira Pharmaceuticals, Inc. (PCRX) Q4 19 Rev. Estimate To 99.2 M From 99.0 M
8/6/2018 7:56:12 AM Wedbush Is Increasing Pacira Pharmaceuticals, Inc. (PCRX) Q3 19 Rev. Estimate To 85.7 M From 85.4 M
8/6/2018 7:56:01 AM Wedbush Is Increasing Pacira Pharmaceuticals, Inc. (PCRX) Q2 19 Rev. Estimate To 85.7 M From 85.5 M
8/6/2018 7:55:51 AM Wedbush Is Raising Pacira Pharmaceuticals, Inc. (PCRX) Q1 19 Rev. Estimate To 80.6 M From 80.4 M
8/6/2018 7:55:37 AM Wedbush Is Increasing Pacira Pharmaceuticals, Inc. (PCRX) FY18 Rev. Estimate To 329.6 M From 311.2 M
8/6/2018 7:55:23 AM Wedbush Is Increasing Pacira Pharmaceuticals, Inc. (PCRX) Q4 18 Rev. Estimate To 89.1 M From 85.3 M
8/6/2018 7:55:12 AM Wedbush Is Raising Pacira Pharmaceuticals, Inc. (PCRX) Q3 18 Rev. Estimate To 81.8 M From 74.0 M
8/6/2018 7:54:26 AM Wedbush Is Raising Pacira Pharmaceuticals, Inc. (PCRX) FY19 Estimate To -1.43 From -1.46
8/6/2018 7:54:01 AM Wedbush Is Increasing Pacira Pharmaceuticals, Inc. (PCRX) Q3 19 Estimate To -0.40 From -0.41
8/6/2018 7:53:49 AM Wedbush Is Raising Pacira Pharmaceuticals, Inc. (PCRX) Q2 19 Estimate To -0.37 From -0.38
8/6/2018 7:53:30 AM Wedbush Is Raising Pacira Pharmaceuticals, Inc. (PCRX) Q1 19 Estimate To -0.42 From -0.43
8/6/2018 7:53:14 AM Wedbush Is Increasing Pacira Pharmaceuticals, Inc. (PCRX) FY18 Estimate To -0.45 From -1.00
8/6/2018 7:53:01 AM Wedbush Is Increasing Pacira Pharmaceuticals, Inc. (PCRX) Q4 18 Estimate To -0.10 From -0.19
8/6/2018 7:52:49 AM Wedbush Is Increasing Pacira Pharmaceuticals, Inc. (PCRX) Q3 18 Estimate To -0.15 From -0.32
8/6/2018 7:52:29 AM Wedbush Reiterates Pacira Pharmaceuticals, Inc. (PCRX) At Outperform With $85 Up From $80 Price Target
8/2/2018 8:14:39 AM Pacira Pharma Q2 EPS $0.06; Non-GAAP EPS $0.24
7/10/2018 7:35:54 AM Pacira Reports Preliminary EXPAREL Net Product Sales Of $80.4 Mln For Q2
6/19/2018 7:35:05 AM Pacira Pharma And Nuance Biotech Announce License Agreement For EXPAREL® In China